Patient Preference With Visicol Tablet Preparation for Colonoscopy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonoscopy. This study will provide answers related to the patient preferences and their acceptance of this new method of bowel preparation.
| Condition |
|---|
|
Preparation for Colonoscopy |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Patient Preference and Acceptance With Sodium Phosphate Tablet Preparation for Colonoscopy: A Prospective Study |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Scheduled colonoscopy list will be reviewed to identify potential subjects for recruitment. A cover letter will be sent to the potential study subject with tablet preparation as an alternative to Golytely preparation ( PEG). For subjects who are willing to participate, a prescription for 28 tablet sodium phosphate bowel preparation as outlined in appendix: A will be mailed. A questionnaire will be given to the patients prior to their colonoscopy to identify their preferences regarding bowel preparation and their acceptance ( see appendix: B).
A separate validated questionnaire will be given to participating physicians after the procedure, to quantitate the colonic cleansing (appendix : C). Adverse events will be documented. A statistical analysis of the results will be done at the end of the study.
Inclusion Criteria:
- Prior colonoscopy with PEG solution in the past one year
- Must be able to swallow tablets
Exclusion Criteria:
- Patients below 18 years and above 100 years.
- Congestive heart failure
- Chronic renal failure
- Pre-existing electrolyte disorder
- Pre-existing mega-colon or a motility disorder.
- Patients with pre-existing seizure disorder.
- Patients scheduled for colonoscopy after 1:00 p.m. will be excluded from the study.
- Pregnant or lactating women
Contacts and Locations| United States, Arizona | |
| Mayo Clinic | |
| Scottsdale, Arizona, United States, 85259 | |
| Principal Investigator: | Suryakanth R. Gurudu, M.D. | Mayo Clinic |
More Information
No publications provided
| Responsible Party: | Suryakanth Gurudu, MD, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT00318305 History of Changes |
| Other Study ID Numbers: | 392-05 |
| Study First Received: | April 24, 2006 |
| Last Updated: | December 1, 2009 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on June 13, 2013